Sanofi Stock Forms Golden Cross As Dupixent Eyes FDA Green Light: Can The Bullish Run Continue?
Sanofi stock is surging with a Golden Cross formation and promising Dupixent results. With FDA review and potential approval, investors are excited.
Fierce Biotech11d
Sanofi bounces midstage ILT2 asset back to Biond Biologics after $125M bet
Four years after Sanofi shelled out $125 million for global rights to Biond Biologic | The company is handing back the tumor ...
Global drug giant boosts Boulder biotech's funding round to $150 million
The company's molecular research and drug-development platform taps what it calls nature's wisdom to drive the discovery of ...
Clinical Trials Arena on MSN19d
Sanofi and Teva report new outcomes from Phase IIb trial of duvakitug
Sanofi and Teva Pharmaceuticals have reported new outcomes from the randomised Phase IIb RELIEVE UCCD trial of human immunoglobulin G 1(IgG1)-λ2 monoclonal antibody, duvakitug, in treating moderate-to ...
Benzinga.com19d
Sanofi/Teva Unveil New Detailed Data For Duvakitug Study Supporting Overall Efficacy For Common Inflammatory Bowel Disease
In ulcerative colitis, duvakitug led to clinical remission in up to 48% of patients, with placebo-adjusted rates of 27% at the highest dose. In Crohn's disease, duvakitug achieved endoscopic ...
chiaki21d
Top 10 thuốc bổ não của Mỹ chất lượng tốt, được chuyên gia khuyên dùng
Cuộc sống hiện đại với nhịp sống phát triển chóng mặt, khiến không ít người phải đối mặt với áp lực và căng thẳng. Và thuốc bổ não của Mỹ nổi lên như một giải pháp hữu hiệu, được ...
Business Insider23d
Sanofi treatment of autoimmune hemolytic anemia granted orphan status
The FDA granted orphan designation to Sanofi (SNY) US Services’ rilzabrutinib as a treatment of autoimmune hemolytic anemia, according to a post to the agency’s website. Published first on ...
Pharmabiz26d
US FDA approves Sanofi-Aventis’ rapid-acting insulin biosimilar product Merilog for improvement of glycaemic control in patients with diabetes
Approval of biosimilar products can increase patient access to safe and effective treatment options. The FDA granted approval of Merilog to Sanofi-Aventis U.S. LLC. “The FDA has now approved three ...
BioSpace26d
Sanofi Challenges Novo With First FDA Nod for NovoLog Biosimilar
In March 2023, Sanofi and Novo came under fire from Sen. Bernie Sanders (I-Vt), who asked the companies to follow in the footsteps of fellow diabetes leader Eli Lilly and lower the price of their ...
Business Insider28d
FDA approves Sanofi biosimilar product for treatment of diabetes
The FDA granted approval of Merilog to Sanofi (SNY)-Aventis U.S. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See the top ...
Seeking Alpha29d
Sanofi and J&J discontinue late stage trial of their experimental E.coli vaccine
Sanofi (NASDAQ:SNY) said on Thursday that it is discontinuing the late-stage trial for its vaccine to prevent E. coli bacteria infection as it failed to demonstrate sufficient efficacy. The ...
Bloomberg L.P.1mon
Sanofi Ends Trial for E. Coli Shot and Takes a $250 Million Hit
Sanofi and Johnson & Johnson ended development of an experimental vaccine after it failed to adequately protect against an invasive form of the digestive pathogen E. coli. Sanofi recorded a $250 ...